Meredith Kaya | executive |
Cedric Francois | executive |
Adam Townsend | executive |
Caroline Baumal | executive |
Timothy Sullivan | executive |
Anupam Rama | analyst |
Derek Archila | analyst |
Eliana Merle | analyst |
Akash Tewari | analyst |
Annabel Samimy | analyst |
Douglas Tsao | analyst |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants on a listen-only mode. [Operator Instructions]. Please note that today's conference is being recorded.